(NewsNation) — The most common type of stroke is an ischemic stroke, accounting for about 87% of all cases, according to the American Stroke Association. It occurs when blood flow to the brain is ...

Glial fibrillary acidic protein (GFAP), a blood biomarker, can be used to rapidly distinguish between hemorrhagic and ischemic stroke, according to a new prospective study. The hope, researchers say, ...

A new blood marker reflects the extent of brain injury after an ischemic stroke and can predict patient outcomes months to ...

PHOENIX, AZ—IV tirofiban lessens early neurological deterioration when given within 24 hours of symptom onset in patients with an acute noncardioembolic ischemic stroke who aren’t treated with IV ...

The role of endovascular therapy for acute stroke with a large infarction has not been extensively studied in differing populations. We conducted a multicenter, prospective, open-label, randomized ...

A new analysis supports the use of intravenous (IV) tenecteplase over IV alteplase (tissue plasminogen activator) for treatment of acute ischemic stroke. The analysis found that patients with ischemic ...

The US Food and Drug Administration (FDA) has approved the thrombolytic tenecteplase (TNKase, Genentech) for treatment of acute ischemic stroke in adults. The drug is administered as a single, ...

The approval marks the first new stroke treatment authorized in nearly 27 years, offering an additional option for managing acute ischemic stroke in Canada. MISSISSAUGA, ON, Dec. 17, 2025 /CNW/ - ...